Читать книгу The SAGE Encyclopedia of Stem Cell Research - Группа авторов - Страница 253

Everolimus (Afinitor) is a targeted therapy drug that seems to help hormone therapy drugs work better. It is approved to be given with exemestane (Aromasin) to treat advanced hormone receptor-positive breast cancer in postmenopausal women. It has also been studied with other hormone therapy drugs and for treatment of earlier-stage breast cancer. In one study, letrozole plus everolimus worked better than letrozole alone in shrinking breast tumors before surgery. It also seemed to help in treating advanced hormone receptor-positive breast cancer when added to tamoxifen. Everolimus is also being studied in combination with chemotherapy and the targeted drug trastuzumab.

Zarish Umar

Independent Scholar

See Also: Breast: Major Pathologies; Cancer Stem Cells: Overview; Fetal Stem Cells.